However, our study and that of Yan et al. indicate clearly that leptin can directly induce adverse changes in breast cancer cell characteristics, and these effects are not restricted to estrogen-dependent breast cancer cells, as they occurred in both hormone receptor positive (MCF7) and negative (MCF10AT1, MDA-MB-468 and MDA-MB-231) cell lines. This evidence concerns the gene LEP and breast carcinoma.